Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Giardia intestinalis | Putative fructose-1,6-bisphosphate aldolase | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | Putative fructose-1,6-bisphosphate aldolase | 323 aa | 361 aa | 25.8 % |
Candida albicans | fructose-bisphosphate aldolase | Putative fructose-1,6-bisphosphate aldolase | 323 aa | 358 aa | 22.6 % |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | Putative fructose-1,6-bisphosphate aldolase | 323 aa | 361 aa | 25.5 % |
Candida albicans | fructose-bisphosphate aldolase | Putative fructose-1,6-bisphosphate aldolase | 323 aa | 358 aa | 22.6 % |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | Putative fructose-1,6-bisphosphate aldolase | 323 aa | 361 aa | 26.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0353 | 0.5088 | 0.5 |
Trypanosoma cruzi | serine peptidase, Clan SC, Family S9B | 0.0068 | 0.0331 | 0.5 |
Giardia lamblia | Fructose-bisphosphate aldolase | 0.0353 | 0.5088 | 0.5 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0353 | 0.5088 | 1 |
Trypanosoma brucei | Dipeptidyl-peptidase 8-like, putative | 0.0068 | 0.0331 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0369 | 0.5351 | 1 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0369 | 0.5351 | 0.5 |
Echinococcus granulosus | proto oncogene serine:threonine protein kinase | 0.0647 | 1 | 1 |
Brugia malayi | Serine/threonine-protein kinase Pim-3 | 0.0647 | 1 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0353 | 0.5088 | 0.5 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0647 | 1 | 1 |
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | 0.0172 | 0.2077 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0353 | 0.5088 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0369 | 0.5351 | 1 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0369 | 0.5351 | 1 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.0201 | 0.256 | 0.2512 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0369 | 0.5351 | 1 |
Trypanosoma cruzi | dipeptidyl-peptidase 8-like serine peptidase | 0.0068 | 0.0331 | 0.5 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0353 | 0.5088 | 1 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0068 | 0.0331 | 0.0268 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S9B | 0.0068 | 0.0331 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0647 | 1 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0353 | 0.5088 | 0.5 |
Leishmania major | dipeptidyl-peptidase 8-like serine peptidase, putative,serine peptidase, Clan SC, Family S9B | 0.0068 | 0.0331 | 0.5 |
Toxoplasma gondii | dipeptidyl peptidase iv (dpp iv) n-terminal region domain-containing protein | 0.0068 | 0.0331 | 0.5 |
Onchocerca volvulus | Serine\/threonine protein kinase homolog | 0.0647 | 1 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0353 | 0.5088 | 0.5 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0369 | 0.5351 | 0.5 |
Echinococcus granulosus | dipeptidyl aminopeptidaseprotein | 0.0201 | 0.256 | 0.2306 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0353 | 0.5088 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0353 | 0.5088 | 0.5 |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0353 | 0.5088 | 0.5 |
Chlamydia trachomatis | oxoacyl-ACP synthase III | 0.0369 | 0.5351 | 0.5 |
Echinococcus multilocularis | dipeptidyl aminopeptidaseprotein | 0.0201 | 0.256 | 0.2306 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0353 | 0.5088 | 0.5 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0201 | 0.256 | 0.2512 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0369 | 0.5351 | 0.5 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0647 | 1 | 1 |
Schistosoma mansoni | subfamily S9B unassigned peptidase (S09 family) | 0.0201 | 0.256 | 0.2306 |
Echinococcus multilocularis | proto oncogene serine:threonine protein kinase | 0.0647 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 14.0919 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.